Skip to content

Research on Multi-Subject Shared Decision-Making Mechanism in Medication Reconciliation for Inpatients with Chronic Disease based on the Value Co-Creation Theory: A Randomized Controlled Trial to Evaluate the Effectiveness of Medication Reconciliation Intervention

Research on Multi-Subject Shared Decision-Making Mechanism in Medication Reconciliation for Inpatients with Chronic Disease based on the Value Co-Creation Theory

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082404
Enrollment
Unknown
Registered
2024-03-28
Start date
2023-07-15
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic disease

Interventions

Sponsors

School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Inpatients with chronic diseases; 2. Patients who took five or more different kinds of drugs at the same time during hospitalization; 3. The age is 18 years and above; 4. Informed consent and willingness to cooperate with this study.

Exclusion criteria

Exclusion criteria: 1. Patients with severe malignant tumors; 2. Patients whose clinical pharmacists are unable to perform medication reorganization within 48 hours; 3. Due to the patient's special circumstances, it is not possible to inquire about their past medication history; 4. Refuse participants.

Design outcomes

Primary

MeasureTime frame
the occurrence of ADEs;30-day and 180-day readmission rate;

Secondary

MeasureTime frame
medicine expenses;rate of emergency visits due to drugs;

Countries

China

Contacts

Public ContactDa Feng

School of Pharmacy, Tongji Medical College of Huazhong University of Science and Technology

fengda@hust.edu.cn+86 158 7236 0068

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026